Lemaitre Vascular Profit Margin

The latest profit margin for LMAT is 25.02% as of June 2026. That compares with 20.08% in the prior-year period — up 24.6% year over year. That is above the Healthcare sector average of 13.76%. Investors often review this figure alongside Lemaitre Vascular's historical trend and sector peers before judging valuation or financial health.

Over the past year, LMAT's profit margin moved from 20.08% to 25.02% — a 24.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lemaitre Vascular's valuation or profitability profile.

Against Healthcare companies, LMAT currently prints 25.02% for profit margin, while the sector average sits near 13.76%. That is roughly 81.9% above the sector mean. Large gaps often invite a closer look at Lemaitre Vascular's growth, margins, and balance sheet.

Profit Margin shows how effectively Lemaitre Vascular converts resources into returns. At 25.02%, LMAT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 20.08% in the prior-year period — up 24.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting LMAT's profit margin (25.02%), review year-over-year change from 20.08%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.